24 March 2026
Fevertree Drinks plc FY25 Preliminary Results to 31 December 2025 Positive strategic progress during the year Comfortable with market expectations for 2026 Highlights £m…
23 March 2026
GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan GSK plc (LSE/NYSE: GSK) today announced that risvutatug rezetecan…
20 March 2026
Unilever PLC Response to media speculation Unilever notes recent media speculation regarding a potential transaction involving its Foods business. The Board believes Foods is…
Ecclesiastical Insurance Office public limited company announces results for the yearended 31 December 2025 Ecclesiastical Insurance Office public limited company (‘Ecclesiastical’, ‘EIO’ or ‘the…
19 March 2026
JPMORGAN GLOBAL GROWTH & INCOME PLC UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 31ST DECEMBER 2025 JPMorgan Global Growth & Income plc…
LONDONMETRIC PROPERTY PLC LONDONMETRIC REFINANCES £1.5 BILLION OF DEBT FACILITIES LondonMetric Property Plc (“LondonMetric”) is pleased to announce the refinancing of £1.5 billion of…
18 March 2026
RUFFER INVESTMENT COMPANY LIMITED (a closed-ended investment company incorporated in Guernsey with registration number 41996) (the “Company“) Interim Financial Report The Company has today,…
PRUDENTIAL PLC FULL YEAR 2025 RESULTS: DELIVERING DOUBLE-DIGIT GROWTH AND INCREASED SHAREHOLDER RETURNS Prudential plc (“Prudential”; HKEX: 2378; LSE: PRU) today announced its financial…